Original paper
The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
Abstract
Although circulating tumor cells (CTCs) were first observed from patients with metastatic malignancies more than 100 years ago, only recently has the clinical and research potential of CTCs become widely recognized. Because CTCs are thought to represent cells that are shed by primary or metastatic tumors, significant interest has focused on examining CTCs as prognostic or predictive biomarkers in several malignancies, including breast and...
Paper Details
Title
The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
Published Date
Apr 10, 2014
Journal
Volume
32
Issue
11
Pages
1104 - 1106
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History